Your browser doesn't support javascript.
loading
Identifying High-Risk Comorbidities Associated with Opioid Use Patterns Using Electronic Health Record Prescription Data.
Jennings, Mariela V; Lee, Hyunjoon; Rocha, Daniel B; Bianchi, Sevim B; Coombes, Brandon J; Crist, Richard C; Faucon, Annika B; Hu, Yirui; Kember, Rachel L; Mallard, Travis T; Niarchou, Maria; Poulsen, Melissa N; Straub, Peter; Urman, Richard D; Walsh, Colin G; Davis, Lea K; Smoller, Jordan W; Troiani, Vanessa; Sanchez-Roige, Sandra.
Afiliação
  • Jennings MV; Department of Psychiatry, University of California San Diego, La Jolla, California, USA.
  • Lee H; Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Rocha DB; Phenomic Analytics and Clinical Data Core, Geisinger, Danville, Pennsylvania, USA.
  • Bianchi SB; Department of Psychiatry, University of California San Diego, La Jolla, California, USA.
  • Coombes BJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
  • Crist RC; Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Faucon AB; Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Hu Y; Department of Population Health Sciences, Geisinger, Danville, Pennsylvania, USA.
  • Kember RL; Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Mallard TT; Psychiatric and Neurodevelopmental Genetics Unit, Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Niarchou M; Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Poulsen MN; Department of Population Health Sciences, Geisinger, Danville, Pennsylvania, USA.
  • Straub P; Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Urman RD; Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Walsh CG; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Davis LK; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Smoller JW; Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Troiani V; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Sanchez-Roige S; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Complex Psychiatry ; 8(1-2): 47-55, 2022 Sep.
Article em En | MEDLINE | ID: mdl-36545045
ABSTRACT

Introduction:

Opioid use disorders (OUDs) constitute a major public health issue, and we urgently need alternative methods for characterizing risk for OUD. Electronic health records (EHRs) are useful tools for understanding complex medical phenotypes but have been underutilized for OUD because of challenges related to underdiagnosis, binary diagnostic frameworks, and minimally characterized reference groups. As a first step in addressing these challenges, a new paradigm is warranted that characterizes risk for opioid prescription misuse on a continuous scale of severity, i.e., as a continuum.

Methods:

Across sites within the PsycheMERGE network, we extracted prescription opioid data and diagnoses that co-occur with OUD (including psychiatric and substance use disorders, pain-related diagnoses, HIV, and hepatitis C) for over 2.6 million patients across three health registries (Vanderbilt University Medical Center, Mass General Brigham, Geisinger) between 2005 and 2018. We defined three groups based on levels of opioid exposure no prescriptions, minimal exposure, and chronic exposure and then compared the comorbidity profiles of these groups to the full registries and to those with OUD diagnostic codes.

Results:

Our results confirm that EHR data reflects known higher prevalence of substance use disorders, psychiatric disorders, medical, and pain diagnoses in patients with OUD diagnoses and chronic opioid use. Comorbidity profiles that distinguish opioid exposure are strikingly consistent across large health systems, indicating the phenotypes described in this new quantitative framework are robust to health systems differences.

Conclusion:

This work indicates that EHR prescription opioid data can serve as a platform to characterize complex risk markers for OUD using existing data.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Complex Psychiatry Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Complex Psychiatry Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos